Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Cell Discovery|May 4, 2021
Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertensionLei-Ke Zhang, Yuan Sun, Haolong Zeng, et al.Cell Reports|April 3, 2020
SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome ActivationShufen Li, Hao Li, Yu-Lan Zhang, et al.Cell Reports|February 10, 2021
SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMOJing Wu, Yuheng Shi, Xiaoyan Pan, et al.Cell Discovery|December 22, 2020
Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertensionLei-Ke Zhang, Yuan Sun, Haolong Zeng, et al.Signal Transduction and Targeted Therapy|August 12, 2021
Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patientsYanbo Wang, Xiaoju Zhu, Xia-Ming Jiang, et al.Acta Pharmacologica Sinica|April 28, 2021
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitorsPeng-Xuan Ren, Wei-Juan Shang, Wan-Chao Yin, et al.Cell Discovery|January 7, 2023
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2Bingqing Xia, Xiaoyan Pan, Rong-Hua Luo, et al.Emerging Microbes & Infections|May 23, 2022
Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethalityZi-Niu Dai, Xue-Fang Peng, Jia-Chen Li, et al.Cell Research|August 25, 2019
Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatalityHao Li, Lei-Ke Zhang, Shu-Fen Li, et al.Acta Pharmacologica Sinica|August 5, 2021
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike proteinLin Wang, Yan Wu, Sheng Yao, et al.Pageof 4